Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ECOGENE-21 is a Canadian non-profit biocluster with internationally recognized expertise in the design and management of clinical trials. It specializes in supporting access to innovations in precision medicine for unmet health needs—especially rare diseases and severe lipid/cardiometabolic conditions. The organization provides advanced R&D capabilities, biobanking services, decentralized trial solutions (including drone delivery), and academic training partnerships. It does not develop its own therapeutic pipeline but enables others’ programs through its infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ECOGENE-21.